Furthermore, the present study does not fully address the specific role(s) of other mitophagy pathways in ALS pathology and progression, such as impaired FUNDC1-dependent (Guo et al, 2024) and BNIP3-dependent mitophagy pathways (Rogers et al, 2017). The gene discussed is FUNDC1; the disease is amyotrophic lateral sclerosis.